A cardiovascular rehabilitation program designed specifically for women
Effects of a Women-Focused Maintenance Cardiovascular Rehabilitation Program on Adherence, Health Related Physical Fitness, and Quality of Life: a Randomized Controlled Trial
This study tests a special heart rehab program for women to see if it helps them stick with their recovery and improve their health after heart problems.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 82 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Lisbon Academic / other |
| Locations | 1 site (Lisbon) |
| Trial ID | NCT06472414 on ClinicalTrials.gov |
What this trial studies
This program focuses on improving adherence to cardiovascular rehabilitation among women with cardiovascular diseases. It includes individualized counseling sessions, educational sessions tailored for women, and supervised exercise training. Participants will undergo a comprehensive assessment of their health and fitness, including body composition, quality of life, and physical activity levels. The program aims to address barriers to participation and enhance the overall health outcomes for women post-cardiovascular events.
Who should consider this trial
Good fit: Ideal candidates are women with documented cardiovascular disease who have completed a phase II rehabilitation program or are within six months of their diagnosis.
Not a fit: Patients who are unable to comply with exercise guidelines or give informed consent may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and health outcomes for women with cardiovascular diseases.
How similar studies have performed: Other studies have shown success in gender-specific approaches to cardiovascular rehabilitation, indicating potential for positive outcomes in this program.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Documented cardiovascular disease: angiographically documented coronary artery disease in at least one major epicardial vessel; those that had clinical evidence of coronary artery disease in the form of previous myocardial infarction; or coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention); heart failure, including cardiac transplantation; heart valve surgery or percutaneous implantation of prosthetic valves or clips; left ventricular assist or resynchronization devices, defibrillators or pacemakers; congenital heart disease. * After phase II cardiovascular rehabilitation program completion or after 6 months of cardiovascular disease diagnosis if no phase II was performed. * Clinically stable and with no contraindications to exercise training. Exclusion Criteria: * Inability to comply with guidelines for exercise testing/training. * Inability to give informed consent. * Significant limiting and/or unstable co morbidities, such as arthritis, metabolic disorders, visual, cognitive, or serious mental illness.
Where this trial is running
Lisbon
- Cardiovascular Centre of the University of Lisbon (CCUL) — Lisbon, Portugal (Recruiting)
Study contacts
- Principal investigator: Madalena Lemos Pires, Masters — Cardiovascular Centre of the University of Lisbon, Faculty of Medicine of Lisbon
- Study coordinator: Madalena Lemos Pires, Masters
- Email: madalenap@edu.ulisboa.pt
- Phone: +351919099699
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.